The current study results indicate that PRMT6 binds to PARP1, recruiting the CRL4B complex which, together, stimulate histone methylation and ubiquitination modification, thereby promoting breast cancer progression (Figure 8J). The gene discussed is PARP1; the disease is breast carcinoma.